Terms ending in 2042
Every in-force patent on Avedro, Inc.'s record whose computed term ends in 2042, whoever holds it now. Soonest term end first, then patent number.
| Patent | Title | Holder | Status | Expires | Confidence |
|---|---|---|---|---|---|
| US 12,016,794 | Photoactivation Systems and Methods for Corneal Cross-Linking Treatments In force · High confidence | Avedro, Inc. | In force | High confidence | |
| US 12,344,598 | Bis(DIAZIRINE) Derivatives as Photo-Crosslinker for Treating Corneal Ectatic Disorders In force · High confidence | Avedro, Inc. | In force | High confidence | |
| US 12,673,925 | Compounds and Compositions for Eye Treatments In force · High confidence | Avedro, Inc. | In force | High confidence | |
| US 11,864,990 | Bioresorbable Corneal Implants In force · High confidence | Avedro, Inc. | In force | High confidence | |
| US 12,293,513 | Systems and Methods for Generating Patient-Specific Corneal Cross-Linking Treatment Patterns In force · High confidence | Avedro, Inc. | In force | High confidence |
5 of 5 patents shown. Soonest term end first, then patent number.
Updated Nov 18, 2026 · includes USPTO assignment data published Nov 17, 2026, status data published Nov 18, 2026 and grant & fee data published Nov 17, 2026 (weekly) · how we know
Computed patent terms end on the dates shown. Related patents and pending applications may cover overlapping subject matter.